FilingFindingsBeta
  • Screeners
  • Trade ideas
Contact View Sample

Stocks
Funds
Insiders
Private Companies
Financials
x
P/E Ratio
  • Low (<15)
  • Profitable (>0)
  • High (>50)
  • Over 5
  • Over 10
  • Over 20
  • Over 30
  • Over 40
  • Under 5
  • Under 10
  • Under 20
  • Under 30
  • Under 40
Show More ▼
Gross Margins
  • Over 10%
  • Over 20%
  • Over 30%
  • Over 40%
  • Over 50%
  • Over 60%
  • Over 70%
  • Over 80%
Show More ▼
Revenue Growth Q/Q
  • Over 5%
  • Over 10%
  • Over 15%
  • Over 20%
  • Over 50%
  • Over 75%
  • Over 100%
  • Over 150%
Show More ▼
EPS Growth Q/Q
  • Over 5%
  • Over 10%
  • Over 15%
  • Over 20%
  • Over 50%
  • Over 75%
  • Over 100%
  • Over 150%
Show More ▼
Debt/Equity
  • High (>0.5)
  • Low (<0.1)
  • Under 1
  • Under 0.8
  • Under 0.5
  • Under 0.3
  • Under 0.1
  • Over 0.1
  • Over 0.3
  • Over 0.5
  • Over 0.8
  • Over 1
Show More ▼
Text
  • Text
  • Text
  • Text
  • Text
  • Text
Show More ▼
Text
  • Text
  • Text
  • Text
  • Text
  • Text
Show More ▼
Text
  • Text
  • Text
  • Text
  • Text
  • Text
Show More ▼
Text
  • Text
  • Text
  • Text
  • Text
  • Text
Show More ▼
Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
Show More ▼
Earnings
x
Upcoming By Date
  • All Upcoming Earnings
  • Upcoming Earnings Tomorrow
  • Upcoming Earnings This Week
  • Upcoming Earnings This Month
  • All Upcoming Conference Calls
  • Upcoming Conference Calls Tomorrow
  • Upcoming Conference Calls This Week
  • Upcoming Conference Calls This Month
Show More ▼
Earnings Guidance
  • All Guidance Calls
  • Raised Guidance
  • Lowered Guidance
  • Positive Guidance
  • Negative Guidance
  • Consistent Positive Guidance
  • Consistent Negative Guidance
  • Suspended Guidance
  • Withdrawn Guidance
Show More ▼
Consensus Earnings
  • Expected to Beat Estimates
  • Expected to Beat Estimates
  • Expected to Beat Estimates
Consensus Revenue
  • Expected to Beat Estimates
  • Expected to Beat Estimates
  • Expected to Beat Estimates
Announced Earnings
  • Exceeded Expectations
  • Beat Expectations
  • Met Expectations
  • Missed Expectations
Announced Revenue
  • Exceeded Expectations
  • Beat Expectations
  • Met Expectations
  • Missed Expectations
Earnings Reaction (Positive)
  • Price Up Post-Earnings
  • Price Up +5% Post-Earnings
  • Price Up +10% Post-Earnings
  • Price Up +15% Post-Earnings
  • Price Up +20% Post-Earnings
Show More ▼
Earnings Reaction (Negative)
  • Price Down Post-Earnings
  • Price Down -5% Post-Earnings
  • Price Down -10% Post-Earnings
  • Price Down -15% Post-Earnings
  • Price Down -20% Post-Earnings
Show More ▼
Positive Trends
  • Beat Expectations Past 2 Quarters
  • Beat Expectations Past 4 Quarters
  • Beat Expectations Past 6 Quarters
  • Beat Expectations Past 8 Quarters
Negative Trends
  • Missed Expectations Past 2 Quarters
  • Missed Expectations Past 4 Quarters
  • Missed Expectations Past 6 Quarters
  • Missed Expectations Past 8 Quarters
Mergers
x
Tender Offers
  • Tender-Offer Solicitation
  • Passive Tender-Offer
  • Hostile Tender-Offer
  • Exclusionary Tender-Offer
  • Creeping Tender-Offer
  • Mini Tender-Offer
  • Partial Tender-Offer
  • Self Tender-Offer
  • Two Tier Tender-Offer
Show More ▼
Acquisitions
  • Conglomerate Mergers
  • Reverse Mergers
  • Triangular Mergers
  • Forward Mergers
  • Concentric Mergers
  • Congeneric Mergers
  • Market Extensions
  • Horizontal Mergers
  • Vertical Mergers
Show More ▼
Successful Mergers
  • Price above Merger Date
  • Price 5% above Merger Date
  • Price 10% above Merger Date
  • Price 25% above Merger Date
  • Price 50% above Merger Date
  • Price above Announcement
  • Price 5% above Announcement Date
  • Price 10% above Announcement Date
  • Price 25% above Announcement Date
  • Price 50% above Announcement Date
Show More ▼
Merger Events
  • Rumors of Merger
  • Announcement of Merger
  • Proxy Filing of Merger
  • Shareholder Vote of Merger
  • Shareholder Approval of Merger
  • Shareholder Rejection of Merger
  • Merger Agreement
  • Amended Merger Agreement
  • Termination of Merger Agreement
Show More ▼
Buyouts
  • Private Buyouts
  • Leveraged Buyouts
  • Management Buyouts
  • Institutional Buyouts
Activist Takeovers
  • Takeover Targets
  • Hostile Takeovers
  • Passive Takeovers
  • Activist Investing
  • Merger Arbitrage
  • Bidding War
Show More ▼
Shareholder Affiliated
  • Business Combination
  • Voting on Merger
  • Shareholder Approval
  • Shareholder Disapproval
Unsuccessful Mergers
  • Price below Merger Date
  • Price 5% below Merger Date
  • Price 10% below Merger Date
  • Price 25% below Merger Date
  • Price 50% below Merger Date
  • Price below Announcement
  • Price 5% below Announcement Date
  • Price 10% below Announcement Date
  • Price 25% below Announcement Date
  • Price 50% below Announcement Date
Show More ▼
Defensive
  • Poison Pill
  • Self Tender Defence
  • Share Repellent
Acquisition Size
  • > $10,000,000,000
  • > $1,000,000,000
  • > $100,000,000
  • > $10,000,000
  • > $1,000,000
IPO's
x
Upcoming IPO's (All)
  • Tomorrow
  • This Week
  • This Month
  • This Quarter
  • This Year
Show More ▼
Upcoming IPO's (Type)
  • Preferred & Income IPOs
  • CEF IPOs
  • ETF IPOs
  • REIT IPOs
  • Fixed Price Issue
  • Book Building Issue
  • Auction IPO's
  • Hybrid IPO's
Show More ▼
Upcoming IPO's (Sector)
  • Financial IPOs
  • Healthcare IPOs
  • Industrials IPOs
  • Technology IPOs
  • Utilities IPOs
  • Energy
  • Basic Materials
  • Communication Services
  • Consumer Cyclical
Show More ▼
Proceeds
  • > $1,000,000,000
  • > $500,000,000
  • > $100,000,000
  • > $10,000,000
  • > $1,000,000
Successful IPO's
  • Price above IPO
  • Price 10% above IPO
  • Price 20% above IPO
  • Price 30% above IPO
  • Price 40% above IPO
  • Price 50% above IPO
Show More ▼
Recently Priced
  • Above $5
  • Above $10
  • Above $25
  • Above $50
  • Above $75
  • Below $5
  • Below $10
  • Below $25
  • Below $50
  • Below $75
Show More ▼
Recent IPO's (Type)
  • Preferred & Income IPOs
  • CEF IPOs
  • ETF IPOs
  • REIT IPOs
  • Fixed Price Issue
  • Book Building Issue
  • Auction IPO's
  • Hybrid IPO's
Show More ▼
Recent IPO's (Sector)
  • Financial IPOs
  • Healthcare IPOs
  • Industrials IPOs
  • Technology IPOs
  • Utilities IPOs
  • Energy
  • Basic Materials
  • Communication Services
  • Consumer Cyclical
Show More ▼
IPO Events
  • Withdrawn
  • Lockup
  • Priced
  • Flipping
Unsuccessful IPO's
  • Price below IPO
  • Price 10% below IPO
  • Price 20% below IPO
  • Price 30% below IPO
  • Price 40% below IPO
  • Price 50% below IPO
Show More ▼
Insider
x
Latest Trading
  • Latest Insider Purchases
  • Latest Insider Purchases $100k+
  • Latest Officer Purchaser $100k+
  • Latest CEO/CFO Purchaser $100k+
  • Latest Insider Sales
  • Latest Insider Sales $100k+
  • Latest Officer Sales $100k+
  • Latest CEO/CFO Sales $100k+
Show More ▼
Top Trading
  • Top Officer Purchases Today
  • Top Officer Purchases Past Week
  • Top Officer Purchases Past Month
  • Top Insider Purchases Today
  • Top Insider Purchases Past Week
  • Top Insider Purchases Past Month
  • Top Insider Sales Today
Show More ▼
Insider Purchases
  • Purchases Before Major News
  • Purchases After Major News
  • Successful Insider Purchases
  • C-Level Purchases
  • Consensus Purchases
  • Largest Purchases
Show More ▼
Insider Sales
  • Sales Before Major News
  • Sales After Major News
  • Successful Insider Sales
  • C-Level Sales
  • Consensus Sales
Show More ▼
Contrarian
  • Down by Half Purchases
  • 52-Week Low Purchases
  • Large Change in Holdings Sales
Show More ▼
Value Transactions
  • Low Price/Earnings Purchases
  • Low Price/Book Purchases
  • Low Price/Sales Purchases
  • High Dividend Yield Purchases
Insider Activity
  • Insider Appointments
  • Insider Departures
  • Fired by the Board
  • Promotions
  • Board Conflict
Show More ▼
CEO's
  • CEO Appointments
  • Top Performing CEO's
  • Top Paid CEO's
  • Industry Leading CEO's
  • Wealthiest CEO's
Show More ▼
Executive Salaries
  • Primarily Stock Options
  • Primarily Bonuses
  • Primarily Non-Equity
  • Primarily Fees
Target Incentives
  • Recently Reached Target
  • Recently Met Target
  • Recently Missed Target
Hedge Funds
x
Largest Portfolios
  • Largest Hedge Funds
  • Largest Mutual Funds
  • Largest Exchange Traded Funds
  • Largest Money Market Funds
  • Largest Broker Dealers
Show More ▼
Top Performing
  • Largest % Return -All Time
  • Largest % Return -This Quarter
  • Largest % Return -This Year
  • Largest % Return -YTD
  • Largest % Return -Past 2 Years
  • Largest % Return -Past 5 Years
  • Largest % Return -Past 10 Years
Show More ▼
Fastest Growing
  • Quarter Up +25%
  • Quarter Up +50%
  • Quarter Up +75%
  • Quarter Up +100%
  • Year Up +25%
  • Year Up +50%
  • Year Up +75%
  • Year Up +100%
Show More ▼
Position Increases
  • +$1,000,000
  • +$5,000,000
  • +$10,000,000
  • +$25,000,000
  • +$50,000,000
  • +$75,000,000
  • +$100,000,000
Show More ▼
Position Decreases
  • -$1,000,000
  • -$5,000,000
  • -$10,000,000
  • -$25,000,000
  • -$50,000,000
  • -$75,000,000
  • -$100,000,000
Show More ▼
Asset Type
  • Majority Exchange Traded Equity
  • U.S Government/Agency Bonds
  • U.S State and Local Bonds
  • Sovereign Bonds
  • Investment Grade Corporate Bonds
  • Derivatives
  • Cash & Cash Equivalents
Show More ▼
Client Type
  • Individual Investors
  • High Net Worth Individuals
  • Banking or Thrift Institution
  • Investment Companies
  • Business Development Companies
  • Pooled Investment Vehicles
  • Pension and profit sharing plans
  • Charitable organizations
  • State or municipal government entities
  • Other investment advisers
  • Insurance companies
  • Sovereign wealth funds
Show More ▼
Compensation Type
  • Percentage of AUM
  • Commissions
  • Hourly Charges
  • Subscription Fees
  • Fixed Fees
  • Performance-Based Fees
Show More ▼
Advisory Activities
  • Financial Planning Services
  • Portfolio Mgmt for individuals
  • Portfolio Mgmt for investment companies
  • Portfolio Mgmt for pooled investment vehicles
  • Portfolio Mgmt for businesses
  • Pension consulting services
  • Security ratings or pricing services
  • Market timing services
  • Educational seminars/workshops
Show More ▼
Additional Activity
  • Broker-Dealer
  • Insurance broker or agent
  • Commodity Pool Operator
  • Futures Commission Merchant
  • Municipal Advisor
  • Accountant or accounting firm
  • Lawyer or Law Firm
Show More ▼
Dividends
x
Highest Yields
  • Highest Yielding (Megacap)
  • Highest Yielding (Midcap)
  • Highest Yielding (Smallcap)
Payout Ratio
  • Less than 100%
  • Less than 75%
  • Less than 50%
  • Less than 25%
  • Less than 20%
  • Less than 15%
  • Less than 10%
  • Less than 5%
Show More ▼
Upcoming Dividends
  • Over 1%
  • Over 2%
  • Over 3%
  • Over 4%
  • Over 5%
  • Over 6%
  • Over 7%
  • Over 8%
  • Over 9%
  • Over 10%
Show More ▼
Dividend Action
  • Declared Dividend
  • Withdraws Dividend
  • Special Dividend
Dividend Increases
  • Increased Dividend
  • Increased By 5%
  • Increased By 10%
  • Increased By 20%
  • Increased By 30%
  • Increased By 50%
  • Increased By 75%
Show More ▼
Dividend Decrease
  • Decreased Dividend
  • Decreased By 5%
  • Decreased By 10%
  • Decreased By 20%
  • Decreased By 30%
  • Decreased By 50%
  • Decreased By 75%
Show More ▼
Next Pay Dates
  • In 1 Month
  • In 2 Months
  • In 3 Months
  • In 4 Months
  • In 5 Months
  • In 6 Months
  • In 7 Months
  • In 8 Months
  • In 9 Months
  • In 10 Months
Show More ▼
Next Ex-Dividend
  • In 1 Month
  • In 2 Months
  • In 3 Months
  • In 4 Months
  • In 5 Months
  • In 6 Months
  • In 7 Months
  • In 8 Months
  • In 9 Months
  • In 10 Months
Consecutive Growth
  • At Least 1 Year
  • At Least 3 Years
  • At Least 5 Years
  • At Least 7 Years
  • At Least 10 Years
  • At Least 12 Years
  • At Least 15 Years
  • At Least 20 Years
  • At Least 25 Years
Show More ▼
3-Year Growth
  • Up By 5%
  • Up By 10%
  • Up By 20%
  • Up By 30%
  • Up By 50%
  • Up By 75%
  • Up By 100%
  • Up By 150%
  • Up By 200%
Show More ▼
FDA
x
COVID-19
  • Awaiting Clinical Trials
  • In Drug Pipeline
  • Stage 1 Approvals
  • Stage 2 Approvals
  • Stage 3 Approvals
  • Largest Price Increase Since Stage 1
  • Largest Price Decrease Since Stage 1
Show More ▼
Recent Product Trials
  • Vaccines & Biologics
  • Prescriptions & Medicines
  • Medical Devices
  • Combination Products
  • Special Nutritional Products
  • Cosmetics
  • Foods
Show More ▼
Drug Status
  • Priority Review
  • Reviewing Application
  • Reviewed
  • Fast Track
  • Breakthrough Therapy
  • Accelerated Approval
  • Refused Approval
  • Approved in other Countries
Show More ▼
Drug Stage
  • Phase 1a
  • Phase 1
  • Phase 1/2
  • Phase 2a
  • Phase 2
  • Phase 2b
  • Phase 2/3
  • Phase 3
  • Phase 4
Show More ▼
Clinical Status
  • NDA Filing
  • sNDA Filing
  • BLA Filing
  • PDUFA
  • PDUFA Priority Review
  • Approved
  • CRL
Show More ▼
Approval Type
  • Labeling
  • Efficacy
  • Standard Approval
Marketing Status
  • Prescription
  • Recalled
  • Postmarket
  • Manufacturing
FDA Approvals
  • Vaccines & Biologics
  • Prescriptions & Medicines
  • Medical devices
  • Combination products
  • Special nutritional products
  • Cosmetics
  • Foods
Show More ▼
FDA Rejections
  • Vaccines & Biologics
  • Prescriptions & Medicines
  • Medical devices
  • Combination products
  • Special nutritional products
  • Cosmetics
  • Foods
Show More ▼
Catalyst Price Reaction
  • Price Above Catalyst
  • Price Below Catalyst
  • Price 10% Aboce Catalyst
  • Price 10% Below Catalyst
  • Price 20% Aboce Catalyst
  • Price 20% Below Catalyst
Show More ▼
Legal
x
Violation Tracker
  • Price Fixing
  • Bid Rigging
  • Horizontal Merger
  • Vertical Merger
  • Territorial Allocation
  • Monopolization
  • Attempt to Monopolize
  • Conspiracy to Monopolize
  • Wire Fraud
  • Mail Fraud
  • Bank Fraud
  • Agreements Not to Compete
  • Exclusive Dealings
  • Boycotts or Refusals to Deal
  • Restraint on Trade
  • Tax Evasion
Show More ▼
Recent Offenses
  • Competition Offences
  • Consumer Protection Offenses
  • Employment Offenses
  • Environmental Offences
  • Financial Offenses
  • Government Contracting Offences
  • Healthcare Offences
  • Miscellaneous Offenses
  • Safety Offences
Show More ▼
Recent Bankruptcies
  • Declared Bankruptcy
  • Received Court Approval
  • Filed Chapter 7: Liquidation Stage
  • Filed Chapter 11: Reorganization Stage
  • Compensated Secured Creditors
  • Compensated Unsecured Creditors
  • Compensated Stockholders
  • Cancelled Existing Equity
  • Cancelled Dividends
  • Ceasing Operations
Show More ▼
SEC Litigations
  • Delinquent Filings
  • Non-Compliance
  • Receiverships
  • Trading Suspensions
  • Administrative Proceedings
Show More ▼
Recent Investigations
  • Announcement of Investigation
  • Investigation of Insider
  • Investigation into Company
  • Investigation into Transaction
  • Investigation into Merger
  • Investigation into Contract
  • Investigation into Fraud
  • Investigation into Theft
  • Investigation into Creative Accounting
Show More ▼

Artificial Intelligence

Meets SEC Filings

  • AI Generated Summaries
  • Instant Fundamental Analysis
  • Hidden Data Uncovered
  • Fraud Detection
  • Much More

View Sample
banner

Investors

  • Shorten analysis time to under 2 minutes rather than the typical 1-2 hours
  • Can identify firm's corporate strategy within disclosures and assess past performance to determine contract/agreement's likelihood
  • Discover new types of investing opportunities with a variety of fintech screeners found nowhere else

Traders

  • Can summarize all major SEC Filings into a condensed summary
  • Can instantaneously provide earnings results for desired publicly traded company
  • Can separate a filing's important information with its non-important information

Analysts

  • Can identify firm's corporate strategy
  • Can determine sentiment of company activity from perspective of investors, traders, regulators, creditors, suppliers
  • Could identify optimism, over-optimism, pessimism, embellishment, distress, and fear within management's footnotes and forward looking statements

Regulators

  • Can automatically detect 134 regulatory violations with >94% accuracy
  • Can automatically detect 232 non-compliance instances >91% accuracy
  • Can automatically detect attributes/characteristics of inadequate disclosures >100% accuracy.
1 Click Analysis

Discover great investment opportunities in seconds. Change the way you research by switching to an AI backed

5 hours into 5 seconds

Enjoy reading corporate disclosures? Neither do we. Let our algorithm do the analysis..Instantly..

Simple Yet Powerful

Our revolutionary algorithm will allow any invester to be ahead of the experts with a simple yet powerful analysis.

Charting

Use our advanced charting to amplify and improve your fundamental research

Historical Financials

Take a deep dive into corporate performance with a trove of historical financial data.

Clean & Simple

FilingFindings categorizes and sorts documents automatically for simple and smooth browsing.

Transcripts

Keep a pulse on corporate statements with earnings and event transcripts.

Important Data Uncovered

Identify information you won't find anywhere else. Don't be misinformed, be more than informed.

Guage FLS Sentiment

FilingFindings allows Forward Looking Statements to be compared and analyzed easily.

Atom Logo Sign in
  • All rights reserved
  • |
  • Legal Term & Conditions
  • |
  • Privacy Policy
  • |
  • Feature Request
  • |
  • Contact Us
  • |
  • Report a Bug
  • |
  • Join Us
  • |
  • Request Access